Top

Published in:

01-09-2009 | Review

Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review

Authors: Blandine Grassiot, Béatrice Desgranges, Francis Eustache, Gilles Defer

Published in: Journal of Neurology | Issue 9/2009

Abstract

Multiple sclerosis is known to be an inflammatory demyelinating disease characterized mainly by multifocal areas of white matter lesions. Recently, cortical lesions and brain atrophy have emerged as new pathological markers of disease progression. Brain tissue loss can now be easily and reproducibly detected and quantified by MRI, which has led to an increasing amount of research correlating brain tissue loss with other MRI markers, such as white matter lesions, and to clinical disabilities (motor or cognitive), in order to assess its clinical relevance. In this review, we summarize the different MRI-based methods used to quantify whole and regional brain atrophy, and discuss the relevance of brain atrophy in MS through its relationship with characteristic brain lesions, disability and cognition. Lastly, we emphasize the role of brain atrophy in different phenotypes of MS. According to this review of the current literature, the grey matter (GM) atrophy is now well-established in MS and has been found to be strongly associated with clinical and cognitive deterioration. This GM volume loss is characterized by a focal atrophy in the deep grey nuclei but also by diffuse cortical atrophy. Phenotypic variation can be associated with different degrees and regional location of brain atrophy but more investigations are necessary to specify the discrepancies against brain atrophy between the different forms of the disease.

Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N (2004) Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63:89–93PubMed

Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L (1995) Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 52:168–172PubMed

Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N (2007) Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 64:1157–1161PubMedCrossRef

Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH (2006) Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol 253:1495–1501PubMedCrossRef

Bakshi R, Ariyaratana S, Benedict RH, Jacobs L (2001) Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 58:742–748PubMedCrossRef

Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F (2001) In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease. Neuroimage 14:298–309PubMedCrossRef

Benedict RH, Bakshi R, Simon JH, Priore R, Miller C, Munschauer F (2002) Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatr Clin Neurosci 14:44–51

Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F, Zivadinov R (2006) Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 63:1301–1306PubMedCrossRef

Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R (2004) Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 61:226–230PubMedCrossRef

10.

Benedict RH, Zivadinov R, Carone DA, Weinstock-Guttman B, Gaines J, Maggiore C, Sharma J, Tomassi MA, Bakshi R (2005) Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am J Neuroradiol 26:1824–1831PubMed

11.

Bermel RA, Innus MD, Tjoa CW, Bakshi R (2003) Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. NeuroReport 14:335–339PubMedCrossRef

12.

Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R (2003) A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 208:57–65PubMedCrossRef

13.

Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W (2001) A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49:793–796PubMedCrossRef

14.

Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283–288PubMedCrossRef

15.

Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158–164PubMedCrossRef

16.

Brex PA, Jenkins R, Fox NC, Crum WR, O’Riordan JI, Plant GT, Miller DH (2000) Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 54:1689–1691PubMed

17.

Brochet B, Bonnet M, Deloire M, Hamel D, Salort-Campana E (2007) Cognitive disorders in multiple sclerosis. Rev Neurol (Paris) 163:697–702

18.

Brochet B, Dousset V (2002) Magnetic resonance imaging in multiple sclerosis. Rev Neurol (Paris) 158:1025–1032

19.

Butzkueven H, Kolbe SC, Jolley DJ, Brown JY, Cook MJ, van der Mei IA, Groom PS, Carey J, Eckholdt J, Rubio JP, Taylor BV, Mitchell PJ, Egan GF, Kilpatrick TJ (2008) Validation of linear cerebral atrophy markers in multiple sclerosis. J Clin Neurosci 15:130–137PubMedCrossRef

20.

Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJ, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254:1212–1220PubMedCrossRef

21.

Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW, Zivadinov R (2006) Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage 29:505–514PubMedCrossRef

22.

Carone DA, Bruce JM, Benedict RH, Yelle V, Dwyer MG, Tjoa CW, Zivadinov R (2006) Regional lesion volume predicts total and then regional gray matter atrophy in MS. In: Neurology pp P02.101, A199

23.

Ceccarelli A, Rocca MA, Falini A, Tortorella P, Pagani E, Rodegher M, Comi G, Scotti G, Filippi M (2007) Normal-appearing white and grey matter damage in MS: a volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 254:513–518PubMedCrossRef

24.

Ceccarelli A, Rocca MA, Pagani E, Ghezzi A, Capra R, Falini A, Scotti G, Comi G, Filippi M (2008) The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study. Neuroimage 39:1499–1509PubMedCrossRef

25.

Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125:327–337PubMedCrossRef

26.

Chard DT, Griffin CM, Rashid W, Davies GR, Altmann DR, Kapoor R, Barker GJ, Thompson AJ, Miller DH (2004) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. **Multiple sclerosis (Houndmills, Basingstoke, England) 10:387–391CrossRef

27.

Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC (2007) Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 34:509–517PubMedCrossRef

28.

Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL (2004) Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23:1168–1175PubMedCrossRef

29.

Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC (2002) Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. NeuroReport 13:1939–1943PubMedCrossRef

30.

Christodoulou C, Krupp LB, Liang Z, Huang W, Melville P, Roque C, Scherl WF, Morgan T, MacAllister WS, Li L, Tudorica LA, Li X, Roche P, Peyster R (2003) Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 60:1793–1798PubMed

31.

Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM (2002) Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52:650–653PubMedCrossRef

32.

Cotton F, Weiner HL, Jolesz FA, Guttmann CR (2003) MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60:640–646PubMedCrossRef

33.

Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, Plant GT, Thompson AJ, Miller DH (2004) Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127:1101–1107PubMedCrossRef

34.

Dalton CM, Miszkiel KA, O’Connor PW, Plant GT, Rice GP, Miller DH (2006) Ventricular enlargement in MS: one-year change at various stages of disease. Neurology 66:693–698PubMedCrossRef

35.

De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157–1162PubMed

36.

Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H, Barroso B, Ouallet JC, Pachai C, Galliaud E, Petry KG, Dousset V, Fabrigoule C, Brochet B (2005) Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76:519–526PubMedCrossRef

37.

Desgranges B, Matuszewski V, Piolino P, Chetelat G, Mezenge F, Landeau B, de la Sayette V, Belliard S, Eustache F (2007) Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study. Neurobiol Aging 28:1904–1913PubMedCrossRef

38.

Filippi M (2000) Enhanced magnetic resonance imaging in multiple sclerosis. **Multiple sclerosis (Houndmills, Basingstoke, England) 6:320–326

39.

Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G (1998) Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 158:148–153PubMedCrossRef

40.

Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC, Miller D, Weinstock-Guttman B, Mass MK, Dougherty DS, Simonian NA (2002) Eight-year follow-up study of brain atrophy in patients with MS. Neurology 59:1412–1420PubMed

41.

Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, Harvey RJ, Rossor MN, Miller DH, Thompson AJ (2000) Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 54:807–812PubMed

42.

Ge Y, Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL (2001) Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220:606–610PubMedCrossRef

43.

Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214:665–670PubMed

44.

Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 26:572–577PubMed

45.

Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA (2005) Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236:254–260PubMedCrossRef

46.

Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F (2007) Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis. Brain Res 1167:71–79PubMedCrossRef

47.

Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36PubMedCrossRef

48.

Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69:1603–1609PubMedCrossRef

49.

Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-Coutinho M, Clanet M, Radue EW, Kappos L (2003) Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. Arch Neurol 60:1736–1739PubMedCrossRef

50.

Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R (2008) Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case control study. J Neurol Neurosurg Psychiatry 79:407–414PubMedCrossRef

51.

Horsfield MA, Rovaris M, Rocca MA, Rossi P, Benedict RH, Filippi M, Bakshi R (2003) Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 216:169–177PubMedCrossRef

52.

Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CR, Bakshi R (2007) Thalamic atrophy and cognition in multiple sclerosis. Neurology 69:1213–1223PubMedCrossRef

53.

Inglese M, Ge Y, Filippi M, Falini A, Grossman RI, Gonen O (2004) Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 21:1825–1829PubMedCrossRef

54.

Jasperse B, Valsasina P, Neacsu V, Knol DL, De Stefano N, Enzinger C, Smith SM, Ropele S, Korteweg T, Giorgio A, Anderson V, Polman CH, Filippi M, Miller DH, Rovaris M, Barkhof F, Vrenken H (2007) Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX. J Magn Reson Imaging 26:881–885PubMedCrossRef

55.

Jasperse B, Vrenken H, Sanz-Arigita E, de Groot V, Smith SM, Polman CH, Barkhof F (2007) Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. Neuroimage 38:529–537PubMedCrossRef

56.

Kalkers NF, Ameziane N, Bot JC, Minneboo A, Polman CH, Barkhof F (2002) Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol 59:1572–1576PubMedCrossRef

57.

Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, Barre L, Constans JM, Viader F, Eustache F, Desgranges B (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30:112–124PubMedCrossRef

58.

Kassubek J, Tumani H, Ecker D, Kurt A, Ludolph AC, Juengling FD (2003) Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. NeuroReport 14:427–430PubMedCrossRef

59.

Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37:253–261PubMedCrossRef

60.

Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17–26PubMedCrossRef

61.

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed

62.

Kutzelnigg A, Lassmann H (2005) Cortical lesions and brain atrophy in MS. J Neurol Sci 233:55–59PubMedCrossRef

63.

Lazeron RH, de Sonneville LM, Scheltens P, Polman CH, Barkhof F (2006) Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. **Multiple sclerosis (Houndmills, Basingstoke, England) 12:760–768CrossRef

64.

Lemaitre H, Crivello F, Grassiot B, Alperovitch A, Tzourio C, Mazoyer B (2005) Age- and sex-related effects on the neuroanatomy of healthy elderly. Neuroimage 26:900–911PubMedCrossRef

65.

Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD (1999) Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 66:323–330PubMedCrossRef

66.

Locatelli L, Zivadinov R, Grop A, Zorzon M (2004) Frontal parenchymal atrophy measures in multiple sclerosis. **Multiple sclerosis (Houndmills, Basingstoke, England) 10:562–568CrossRef

67.

Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, Miller DH, Thompson AJ (1996) Progressive cerebral atrophy in multiple sclerosis. **A serial MRI study, Brain 119(Pt 6):2009–2019

68.

Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695PubMedCrossRef

69.

Miller DH, Thompson AJ, Filippi M (2003) Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 250:1407–1419PubMedCrossRef

70.

Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D (2006) Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 30:891–898PubMedCrossRef

71.

Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA (2007) Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 28:1645–1649PubMedCrossRef

72.

Pagani E, Rocca MA, Gallo A, Rovaris M, Martinelli V, Comi G, Filippi M (2005) Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 26:341–346PubMed

73.

Pelletier D, Garrison K, Henry R (2004) Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 14:11S–19SPubMedCrossRef

74.

Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Cherif AA (2001) A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58:105–111PubMedCrossRef

75.

Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400PubMedCrossRef

76.

Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, Alfano B, Salvatore M (2006) Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 29:859–867PubMedCrossRef

77.

Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A (2003) Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 18:360–366PubMedCrossRef

78.

Rao SM (1995) Neuropsychology of multiple sclerosis. Curr Opin Neurol 8:216–220PubMedCrossRef

79.

Rovaris M, Comi G, Filippi M (2006) MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 245:111–116PubMedCrossRef

80.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E (1997) Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 42:379–382PubMedCrossRef

81.

Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA (2001) Use of the multiple sclerosis functional composite to predict disability in relapsing MS. Neurology 56:1324–1330PubMed

82.

Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS: Multiple Sclerosis Collaborative Research Group. Neurology 53:1698–1704PubMed

83.

Sailer M, Fischl B, Salat D, Tempelmann C, Schonfeld MA, Busa E, Bodammer N, Heinze HJ, Dale A (2003) Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126:1734–1744PubMedCrossRef

84.

Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R (2005) The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs white matter with misclassification correction. Neuroimage 26:1068–1077PubMedCrossRef

85.

Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R (2006) Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 66:685–692PubMedCrossRef

86.

Sastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramio-Torrenta L, Miller DH, Thompson AJ (2005) Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 128:1454–1460PubMedCrossRef

87.

Sastre-Garriga J, Ingle GT, Chard DT, Ramio-Torrenta L, Miller DH, Thompson AJ (2004) Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 22:353–359PubMedCrossRef

88.

Sepulcre J, Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ (2006) Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 63:1175–1180PubMedCrossRef

89.

Sharma J, Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Munschauer FEIII, Bakshi R (2004) Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. AJNR Am J Neuroradiol 25:985–996PubMed

90.

Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer SY (2008) Regional hippocampal atrophy in multiple sclerosis. Brain 131:1134–1141PubMedCrossRef

91.

Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FEIII, Brownscheidle CM (1999) A longitudinal study of brain atrophy in relapsing multiple sclerosis: the Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 53:139–148PubMed

92.

Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479–489PubMedCrossRef

93.

Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Hintzen R, Montalban X, Polman CH, Rovira A, de Sa J, Thompson AJ (2000) One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 68:713–718PubMedCrossRef

94.

Taylor I, Butzkueven H, Litewka L, MacGregor LR, Szoeke C, Cook M, Mitchell P, Kilpatrick TJ, Tubridy N (2004) Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy. J Clin Neurosci 11:153–158PubMedCrossRef

95.

Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B (2005) Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 65:280–285PubMedCrossRef

96.

Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, Dwyer MG, Carone D, Srinivasaraghavan B, Yella V, Abdelrahman N, Munschauer F, Bakshi R, Zivadinov R (2007) Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 36:1294–1300PubMedCrossRef

97.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH (2005) Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 64:1001–1007PubMed

98.

Turner B, Ramli N, Blumhardt LD, Jaspan T (2001) Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates. Neuroradiology 43:608–614PubMedCrossRef

99.

Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M (2005) Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Neurology 65:1126–1128PubMedCrossRef

100.

Vovk U, Pernus F, Likar B (2007) A review of methods for correction of intensity inhomogeneity in MRI. IEEE Trans Med Imaging 26:405–421PubMedCrossRef

101.

Vrenken H, Geurts JJ, Knol DL, van Dijk LN, Dattola V, Jasperse B, van Schijndel RA, Polman CH, Castelijns JA, Barkhof F, Pouwels PJ (2006) Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240:811–820PubMedCrossRef

102.

Zivadinov R, Cox JL (2007) Neuroimaging in multiple sclerosis. Int Rev Neurobiol 79:449–474PubMedCrossRef

103.

Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M (2001) A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70:773–780PubMedCrossRef

Title: Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review
Authors: Blandine Grassiot
Béatrice Desgranges
Francis Eustache
Gilles Defer
Publication date: 01-09-2009
Publisher: D. Steinkopff-Verlag
Published in: Journal of Neurology / Issue 9/2009
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-009-5108-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2009

Predicting hospital mortality using APACHE II scores in neurocritically ill patients: a prospective study

Acute aphasia after right hemisphere stroke

Communications of the European Neurological Society

Brain metastases in patients with pelvic or abdominal malignancy do not prevail in the posterior fossa: a retrospective study

A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease

Free caspase activity in CSF of patients with dementia